Dietary Supplement
Probiotic dietary supplement
Probiotic dietary supplement is a dietary supplement with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Phase Distribution
Ph phase_3
1
17%
Ph not_applicable
5
83%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (16.7%)
N/A5 (83.3%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completednot_applicable
Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
NCT07346924
completedphase_3
Group B Streptococcus Response After Probiotic Exposure
NCT04721912
completednot_applicable
A Pilot Study to Assess the Safety Profile of resB®
NCT05173168
completednot_applicable
Prospective Tolerability Assessment of a Probiotic Dietary Supplement
NCT04044144
completednot_applicable
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
NCT01479478
Clinical Trials (6)
Showing 6 of 6 trials
NCT07346924Not Applicable
Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
NCT04721912Phase 3
Group B Streptococcus Response After Probiotic Exposure
NCT05173168Not Applicable
A Pilot Study to Assess the Safety Profile of resB®
NCT04044144Not Applicable
Prospective Tolerability Assessment of a Probiotic Dietary Supplement
NCT01479478Not Applicable
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
NCT02249325Not Applicable
Quasi Experiment of Prenatal Probiotics Against Group B Streptococcus Colonization
All 6 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 6